$RHE
Regional Health Properties Inc

2024 Q2 Form 10-Q Financial Statement

#000095017024060062 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.325M $4.127M
YoY Change -5.94% 5.66%
Cost Of Revenue $2.183M $2.101M
YoY Change 1.11% -17.19%
Gross Profit $2.142M $2.026M
YoY Change -12.18% 47.99%
Gross Profit Margin 49.53% 49.09%
Selling, General & Admin $1.414M $1.809M
YoY Change 6.32% 19.64%
% of Gross Profit 66.01% 89.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $514.0K $511.0K
YoY Change -26.78% 0.2%
% of Gross Profit 24.0% 25.22%
Operating Expenses $4.111M $4.421M
YoY Change -6.82% -4.95%
Operating Profit $214.0K -$294.0K
YoY Change 15.05% -60.54%
Interest Expense $669.0K $674.0K
YoY Change -1.47% -0.88%
% of Operating Profit 312.62%
Other Income/Expense, Net -$920.0K -$668.0K
YoY Change 5.63% -46.43%
Pretax Income -$706.0K -$962.0K
YoY Change 3.07% -51.71%
Income Tax
% Of Pretax Income
Net Earnings -$706.0K -$962.0K
YoY Change 3.07% -51.71%
Net Earnings / Revenue -16.32% -23.31%
Basic Earnings Per Share -$0.38 -$0.52
Diluted Earnings Per Share -$0.38 -$0.52
COMMON SHARES
Basic Shares Outstanding 1.839M 1.839M
Diluted Shares Outstanding 1.847M 1.839M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $679.0K $752.0K
YoY Change -64.75% -73.17%
Cash & Equivalents $700.0K $800.0K
Short-Term Investments
Other Short-Term Assets $894.0K $410.0K
YoY Change -78.59% -88.32%
Inventory
Prepaid Expenses
Receivables $1.817M $1.464M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.390M $2.626M
YoY Change -65.75% -73.83%
LONG-TERM ASSETS
Property, Plant & Equipment $39.87M $44.89M
YoY Change -13.83% -2.65%
Goodwill $1.585M $1.585M
YoY Change 0.0% 0.0%
Intangibles $11.62M $11.73M
YoY Change -3.6% -3.58%
Long-Term Investments
YoY Change
Other Assets $7.746M $3.223M
YoY Change 163.56%
Total Long-Term Assets $57.93M $58.60M
YoY Change 3.53% 4.79%
TOTAL ASSETS
Total Short-Term Assets $3.390M $2.626M
Total Long-Term Assets $57.93M $58.60M
Total Assets $61.32M $61.23M
YoY Change -6.88% -7.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.615M $3.106M
YoY Change 19.07% -1.68%
Accrued Expenses $7.016M $7.047M
YoY Change 45.2% 34.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.63M $10.15M
YoY Change 35.12% 20.68%
LONG-TERM LIABILITIES
Long-Term Debt $50.25M $50.01M
YoY Change -3.43% -2.92%
Other Long-Term Liabilities $5.249M $1.797M
YoY Change 12.18% -57.44%
Total Long-Term Liabilities $50.25M $50.01M
YoY Change -3.43% -2.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.63M $10.15M
Total Long-Term Liabilities $50.25M $50.01M
Total Liabilities $62.74M $61.96M
YoY Change -2.85% -3.41%
SHAREHOLDERS EQUITY
Retained Earnings -$83.57M -$82.86M
YoY Change 3.57% -32.85%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.417M -$734.0K
YoY Change
Total Liabilities & Shareholders Equity $61.32M $61.23M
YoY Change -6.88% -7.17%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$706.0K -$962.0K
YoY Change 3.07% -51.71%
Depreciation, Depletion And Amortization $514.0K $511.0K
YoY Change -26.78% 0.2%
Cash From Operating Activities $505.0K $600.0K
YoY Change 41.06% -76.92%
INVESTING ACTIVITIES
Capital Expenditures $340.0K $55.00K
YoY Change -60.09% 2650.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$340.0K -$55.00K
YoY Change -60.09% 2650.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -566.0K -751.0K
YoY Change 23.04% 9.64%
NET CHANGE
Cash From Operating Activities 505.0K 600.0K
Cash From Investing Activities -340.0K -55.00K
Cash From Financing Activities -566.0K -751.0K
Net Change In Cash -401.0K -209.0K
YoY Change -57.97% -110.94%
FREE CASH FLOW
Cash From Operating Activities $505.0K $600.0K
Capital Expenditures $340.0K $55.00K
Free Cash Flow $165.0K $545.0K
YoY Change -133.4% -79.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001004724
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-33135
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Regional Health Properties, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5166048
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1050 Crown Pointe Parkway
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 720
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30338
CY2024Q1 dei City Area Code
CityAreaCode
678
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
869-5116
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1839028
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44885000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45337000
CY2024Q1 us-gaap Cash
Cash
752000
CY2023Q4 us-gaap Cash
Cash
953000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
3223000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
3231000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2056000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2040000
CY2024Q1 us-gaap Receivables From Customers
ReceivablesFromCustomers
1464000
CY2023Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
1403000
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
410000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
609000
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
1034000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1044000
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2024Q1 rhe Finite Lived Intangible Assets Lease Rights Net
FiniteLivedIntangibleAssetsLeaseRightsNet
83000
CY2023Q4 rhe Finite Lived Intangible Assets Lease Rights Net
FiniteLivedIntangibleAssetsLeaseRightsNet
87000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2455000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2556000
CY2024Q1 us-gaap Goodwill
Goodwill
1585000
CY2023Q4 us-gaap Goodwill
Goodwill
1585000
CY2024Q1 us-gaap Security Deposit
SecurityDeposit
4000
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
4000
CY2024Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
2859000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-550000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-668000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1230000
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
2901000
CY2024Q1 us-gaap Assets
Assets
61225000
CY2023Q4 us-gaap Assets
Assets
62181000
CY2024Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
43500000
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
43855000
CY2024Q1 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
5993000
CY2023Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
5991000
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
516000
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
889000
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3106000
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2493000
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4240000
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4060000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2807000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2917000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
1797000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
1791000
CY2024Q1 us-gaap Liabilities
Liabilities
61959000
CY2023Q4 us-gaap Liabilities
Liabilities
61996000
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1850000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1850000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1839000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1839000
CY2024Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
63102000
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
63059000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82864000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81902000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-734000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
185000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61225000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62181000
CY2024Q1 us-gaap Revenues
Revenues
4127000
CY2023Q1 us-gaap Revenues
Revenues
3906000
CY2024Q1 rhe Patient Care Expense
PatientCareExpense
2101000
CY2023Q1 rhe Patient Care Expense
PatientCareExpense
2321000
CY2024Q1 rhe Facility Rent Expense
FacilityRentExpense
149000
CY2023Q1 rhe Facility Rent Expense
FacilityRentExpense
149000
CY2024Q1 rhe Cost Of Management Fees
CostOfManagementFees
0
CY2023Q1 rhe Cost Of Management Fees
CostOfManagementFees
141000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
511000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
510000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1632000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-962000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1531000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4421000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4668000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-294000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-762000
CY2024Q1 us-gaap Interest Expense
InterestExpense
674000
CY2023Q1 us-gaap Interest Expense
InterestExpense
680000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1992000
CY2024Q1 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
0
CY2023Q1 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
2249000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-962000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4241000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1839000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1839000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1862000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1862000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
185000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-962000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-734000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3716000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1992000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1805000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-962000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1992000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
511000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
510000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
43000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
81000
CY2024Q1 rhe Rent Expense Less Than In Excess Of Cash Paid
RentExpenseLessThanInExcessOfCashPaid
-9000
CY2023Q1 rhe Rent Expense Less Than In Excess Of Cash Paid
RentExpenseLessThanInExcessOfCashPaid
-4000
CY2024Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
121000
CY2023Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
26000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
25000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
19000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
168000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3357000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-209000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-546000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
793000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-107000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
145000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
597000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2597000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000
CY2024Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
378000
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
322000
CY2024Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
373000
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
363000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-751000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-685000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-209000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1910000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4184000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3909000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3975000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5819000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
677000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
650000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</span></p>
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to the amounts reported in the prior period in order to conform to the current period's presentation. A reclassification has been made to certain expenses reported on the consolidated statements of operations in the prior period in order to conform to the current period's presentation.</span></p>
CY2024Q1 rhe Percentage Of Revenue Recognized From Government Sources
PercentageOfRevenueRecognizedFromGovernmentSources
0.90
CY2024Q1 rhe Percentage Of Reserve For Patient Care Receivables
PercentageOfReserveForPatientCareReceivables
0.015
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3520000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3443000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2056000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2040000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1464000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1403000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
400000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3106000
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2493000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
1800000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
1800000
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
65000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
48000
CY2024Q1 rhe Antidilutive Securities Excluded From Computation Of Earnings Per Share Intrinsic Value
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareIntrinsicValue
0
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
800000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
600000
CY2024Q1 rhe Accumulated And Unpaid Dividends On Series A Preferred Stock
AccumulatedAndUnpaidDividendsOnSeriesAPreferredStock
50400000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
50000000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
1000000
CY2024Q1 rhe Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Subject To Non Default In Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsSubjectToNonDefaultInPayments
1700000
CY2024Q1 us-gaap Cash
Cash
752000
CY2023Q4 us-gaap Cash
Cash
953000
CY2024Q1 rhe Pledged Assets Not Separately Reported Other Financial Instrument
PledgedAssetsNotSeparatelyReportedOtherFinancialInstrument
159000
CY2023Q4 rhe Pledged Assets Not Separately Reported Other Financial Instrument
PledgedAssetsNotSeparatelyReportedOtherFinancialInstrument
159000
CY2024Q1 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
2126000
CY2023Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
2125000
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
621000
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
630000
CY2024Q1 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2023Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
3223000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
3231000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3975000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4184000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68335000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68408000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23450000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23071000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44885000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45337000
CY2024Q1 us-gaap Land Improvements
LandImprovements
100000
CY2024Q1 us-gaap Depreciation
Depreciation
403000
CY2023Q1 us-gaap Depreciation
Depreciation
400000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
511000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
510000
CY2023Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16923000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5086000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11837000
CY2023Q4 us-gaap Goodwill
Goodwill
1585000
CY2024Q1 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16923000
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5194000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11729000
CY2024Q1 us-gaap Goodwill
Goodwill
1585000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments Due Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueRemainderOfFiscalYear
510000
CY2024Q1 rhe Lessee Operating Lease Accretion On Lease Liability Due Remainder Of Fiscal Year
LesseeOperatingLeaseAccretionOnLeaseLiabilityDueRemainderOfFiscalYear
16000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
494000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments Due Year One
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearOne
672000
CY2024Q1 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year One
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearOne
66000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
606000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Two
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearTwo
658000
CY2024Q1 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Two
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearTwo
109000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
549000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Three
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearThree
671000
CY2024Q1 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Three
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearThree
155000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
516000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFour
685000
CY2024Q1 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFour
198000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
487000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments Due After Year Five
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueAfterYearFive
230000
CY2024Q1 rhe Lessee Operating Lease Accretion Of Lease Liability Due After Year Five
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueAfterYearFive
75000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
155000
CY2024Q1 rhe Lessee Operating Lease Liability Future Rental Payments
LesseeOperatingLeaseLiabilityFutureRentalPayments
3426000
CY2024Q1 rhe Lessee Operating Lease Accretion Of Lease Liability
LesseeOperatingLeaseAccretionOfLeaseLiability
619000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2807000
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0798
CY2024Q1 rhe Number Of Owned Facilities Lessor
NumberOfOwnedFacilitiesLessor
9
CY2024Q1 rhe Number Of Owned Facilities
NumberOfOwnedFacilities
11
CY2024Q1 rhe Number Of Owned Facilities Sub Lessor
NumberOfOwnedFacilitiesSubLessor
1
CY2024Q1 rhe Number Of Sublease Agreements Executed Owned By Company
NumberOfSubleaseAgreementsExecutedOwnedByCompany
10
CY2024Q1 rhe Weighted Average Remaining Lease Term Facilities Lessor
WeightedAverageRemainingLeaseTermFacilitiesLessor
P5Y3M18D
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
4948000
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
6696000
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
6801000
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
6909000
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
6758000
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
8227000
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
40339000
CY2024Q1 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
365000
CY2023Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
255000
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3055000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3077000
CY2023Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
61000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
223000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
225000
CY2024Q1 rhe Insurance Escrow Current
InsuranceEscrowCurrent
116000
CY2023Q4 rhe Insurance Escrow Current
InsuranceEscrowCurrent
98000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
481000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
344000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4240000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4060000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
51058000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
51802000
CY2024Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
937000
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
954000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
112000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
113000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
50009000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
50735000
CY2024Q1 rhe Debt Instrument Number Of Credit Related Instruments
DebtInstrumentNumberOfCreditRelatedInstruments
16
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
1297000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2265000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
8741000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
1560000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
1657000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
35538000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
51058000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
112000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
937000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
50009000
CY2024Q1 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
43000
CY2023Q1 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
81000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.76
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M7D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0381
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2714
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
57000
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
9.41
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
44000
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
11.55
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
(i) Real Estate Services, which consists of the leasing and subleasing of long-term care and senior living facilities to third-party tenants, including the Company's management of three facilities on behalf of third-party owners which ended on December 31, 2023; and (ii) Healthcare Services, which consists of the operation of the Meadowood and Glenvue facilities.
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1818000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1708000
CY2024Q1 us-gaap Revenues
Revenues
4127000
CY2023Q1 us-gaap Revenues
Revenues
3906000
CY2024Q1 rhe Patient Care Expense
PatientCareExpense
2101000
CY2023Q1 rhe Patient Care Expense
PatientCareExpense
2321000
CY2024Q1 rhe Facility Rent Expense
FacilityRentExpense
149000
CY2023Q1 rhe Facility Rent Expense
FacilityRentExpense
149000
CY2023Q1 rhe Cost Of Management Fees
CostOfManagementFees
141000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
511000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
510000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1632000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1531000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4421000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4668000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-294000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-762000
CY2024Q1 us-gaap Interest Expense
InterestExpense
674000
CY2023Q1 us-gaap Interest Expense
InterestExpense
680000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-550000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-668000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1230000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-962000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1992000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-060062-index-headers.html Edgar Link pending
0000950170-24-060062-index.html Edgar Link pending
0000950170-24-060062.txt Edgar Link pending
0000950170-24-060062-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rhe-20240331.htm Edgar Link pending
rhe-20240331.xsd Edgar Link pending
rhe-ex31_1.htm Edgar Link pending
rhe-ex31_2.htm Edgar Link pending
rhe-ex32_1.htm Edgar Link pending
rhe-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rhe-20240331_htm.xml Edgar Link completed